Kim Margolin
Impact in
- Oncology top 0.05%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 0.2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 159
- Cancer Immunotherapy and Biomarkers 79
- CAR-T cell therapy research 51
- Cancer Treatment and Pharmacology 19
-
- Brain Metastases and Treatment 36
- Renal cell carcinoma treatment 25
- Co-authors
- Michael B. Atkins (49 shared papers)Geoffrey R. Weiss (32 shared papers)Janice P. Dutcher (27 shared papers)Sylvia Lee (3 shared papers)Mario Sznol (22 shared papers)F. Stephen Hodi (19 shared papers)Omid Hamid (17 shared papers)Richard I. Fisher (19 shared papers)
- Journals
- Journal of Clinical Oncology (85 papers)Cancer Chemotherapy and Pharmacology (15 papers)Annals of Oncology (13 papers)Cancer (11 papers)Current Oncology Reports (10 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Kim Margolin
303 papers receiving 17.5k citations
Kim Margolin's Hit Papers
Peers
Comparison fields: 5 of 136
- Oncology 9.0k
- Immunology 4.8k
- Pulmonary and Respiratory Medicine 4.8k
- Cancer Research 2.0k
- Genetics 903
Countries citing papers authored by Kim Margolin
This map shows the geographic impact of Kim Margolin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Margolin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Margolin more than expected).
Fields of papers citing papers by Kim Margolin
This network shows the impact of papers produced by Kim Margolin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Margolin. The network helps show where Kim Margolin may publish in the future.
Co-authors
The 25 scholars most cited alongside Kim Margolin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 311 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma Hit paper breakdown → | 2015 | 1571 |
| 2 | High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993 Hit paper breakdown → | 1999 | 1535 |
| 3 | Sunitinib in Patients With Metastatic Renal Cell Carcinoma Hit paper breakdown → | 2006 | 971 |
| 4 | Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial Hit paper breakdown → | 2014 | 874 |
| 5 | Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial Hit paper breakdown → | 2012 | 830 |
| 6 | Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer Hit paper breakdown → | 2001 | 746 |
| 7 | Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma Hit paper breakdown → | 2004 | 602 |
| 8 | Cytokines in Cancer Immunotherapy Hit paper breakdown → | 2011 | 527 |
| 9 | 2008 | 320 | |
| 10 | 2001 | 300 | |
| 11 | 1989 | 262 | |
| 12 | 2003 | 210 | |
| 13 | 2007 | 203 | |
| 14 | 2013 | 199 | |
| 15 | 2005 | 189 | |
| 16 | 2001 | 188 | |
| 17 | 2016 | 184 | |
| 18 | 1989 | 180 | |
| 19 | 1990 | 178 | |
| 20 | 2016 | 171 |
About Kim Margolin
Kim Margolin is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Immunology and Surgery, having authored 311 papers that have together received 18.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (79 papers), Immunotherapy and Immune Responses (52 papers), CAR-T cell therapy research (51 papers), Brain Metastases and Treatment (36 papers), Melanoma and MAPK Pathways (30 papers), Renal cell carcinoma treatment (25 papers), Cancer Treatment and Pharmacology (19 papers) and Testicular diseases and treatments (18 papers). The work is most often cited by research in Oncology (9.0k citations), Immunology (4.8k citations), Pulmonary and Respiratory Medicine (4.8k citations), Cancer Research (2.0k citations) and Genetics (903 citations). Kim Margolin has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Michael B. Atkins, Geoffrey R. Weiss, Janice P. Dutcher, Sylvia Lee, Mario Sznol, F. Stephen Hodi, Omid Hamid, Richard I. Fisher, James H. Doroshow and Jedd D. Wolchok. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Annals of Oncology, Cancer and Current Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.